BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38184010)

  • 1. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Sekino Y; Tsutani Y; Nakajima R; Aokage K; Saji H; Tsuboi M; Okada M; Asamura H; Nakamura K; Fukuda H; Watanabe SI; ;
    Lancet Respir Med; 2024 Feb; 12(2):105-116. PubMed ID: 38184010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
    Saji H; Okada M; Tsuboi M; Nakajima R; Suzuki K; Aokage K; Aoki T; Okami J; Yoshino I; Ito H; Okumura N; Yamaguchi M; Ikeda N; Wakabayashi M; Nakamura K; Fukuda H; Nakamura S; Mitsudomi T; Watanabe SI; Asamura H;
    Lancet; 2022 Apr; 399(10335):1607-1617. PubMed ID: 35461558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):518-525. PubMed ID: 28082475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
    Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
    J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multi-Institutional, Randomized, Phase III Trial Comparing Anatomical Segmentectomy and Lobectomy for Clinical Stage IA3 Pure-Solid Non-Small-Cell Lung Cancer: West Japan Oncology Group Study WJOG16923L (STEP UP Trial).
    Kamigaichi A; Hamada A; Tsuboi M; Yoshimura K; Okamoto I; Yamamoto N; Tsutani Y
    Clin Lung Cancer; 2024 Jun; 25(4):384-388.e1. PubMed ID: 38360496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobectomy Versus Segmentectomy in Radiologically Pure Solid Small-Sized Non-Small Cell Lung Cancer.
    Koike T; Kitahara A; Sato S; Hashimoto T; Aoki T; Koike T; Yoshiya K; Toyabe S; Tsuchida M
    Ann Thorac Surg; 2016 Apr; 101(4):1354-60. PubMed ID: 26794890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Segmentectomy versus lobectomy for small-sized pure solid non-small cell lung cancer.
    Li Z; Xu W; Pan X; Wu W; Chen L
    Thorac Cancer; 2023 Apr; 14(11):1021-1028. PubMed ID: 36882365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segmentectomy for patients with early-stage pure-solid non-small cell lung cancer.
    Kamigaichi A; Hamada A; Tsutani Y
    Front Oncol; 2023; 13():1287088. PubMed ID: 38023140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer.
    Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Ito H; Nakayama H; Ikeda N; Okada M
    Eur J Cardiothorac Surg; 2020 Dec; 58(6):1245-1253. PubMed ID: 32893296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes in a prospective randomized multicenter Phase III trial comparing patients undergoing anatomical segmentectomy versus standard lobectomy for non-small cell lung cancer up to 2 cm.
    Stamatis G; Leschber G; Schwarz B; Brintrup DL; Flossdorf S; Passlick B; Hecker E; Kugler C; Eichhorn M; Krbek T; Eggeling S; Hatz R; Müller MR; Hillinger S; Aigner C; Jöckel KH
    Lung Cancer; 2022 Oct; 172():108-116. PubMed ID: 36058174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial.
    Suzuki K; Saji H; Aokage K; Watanabe SI; Okada M; Mizusawa J; Nakajima R; Tsuboi M; Nakamura S; Nakamura K; Mitsudomi T; Asamura H; ;
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):895-907. PubMed ID: 31078312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
    Aokage K; Suzuki K; Saji H; Wakabayashi M; Kataoka T; Sekino Y; Fukuda H; Endo M; Hattori A; Mimae T; Miyoshi T; Isaka M; Yoshioka H; Nakajima R; Nakagawa K; Okami J; Ito H; Kuroda H; Tsuboi M; Okumura N; Takahama M; Ohde Y; Aoki T; Tsutani Y; Okada M; Watanabe SI;
    Lancet Respir Med; 2023 Jun; 11(6):540-549. PubMed ID: 36893780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).
    Nakamura K; Saji H; Nakajima R; Okada M; Asamura H; Shibata T; Nakamura S; Tada H; Tsuboi M
    Jpn J Clin Oncol; 2010 Mar; 40(3):271-4. PubMed ID: 19933688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmentectomy Versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer.
    Tsubokawa N; Tsutani Y; Miyata Y; Handa Y; Misumi K; Hanaki H; Hida E; Okada M
    World J Surg; 2018 Aug; 42(8):2493-2501. PubMed ID: 29423740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes.
    Roman M; Labbouz S; Valtzoglou V; Ciesla A; Hawari M; Addae-Boateng E; Thorpe JA; Duffy JP; Majewski A
    Eur J Surg Oncol; 2019 May; 45(5):845-850. PubMed ID: 30409440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.
    Kodama K; Higashiyama M; Okami J; Tokunaga T; Imamura F; Nakayama T; Inoue A; Kuriyama K
    Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer.
    Chan EG; Chan PG; Mazur SN; Normolle DP; Luketich JD; Landreneau RJ; Schuchert MJ
    J Thorac Cardiovasc Surg; 2021 May; 161(5):1639-1648.e2. PubMed ID: 32331817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.
    Dziedzic R; Zurek W; Marjanski T; Rudzinski P; Orlowski TM; Sawicka W; Marczyk M; Polanska J; Rzyman W
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):363-369. PubMed ID: 28402455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of thoracoscopic segmentectomy and thoracoscopic lobectomy on the patients with non-small cell lung cancer: a propensity score matching study.
    Hwang Y; Kang CH; Kim HS; Jeon JH; Park IK; Kim YT
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):273-8. PubMed ID: 25406426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.